EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Natural Products Targeting Acetylation in Bladder Cancer: Mechanistic Basis, Therapeutic Potential, and Future Perspectives

Wei Li, Da Liu, Qinzhamusu Yin, Yiwen Geng, Yang Liu iD, Yong Wang

Current Issues in Molecular Biology · 08.05.2026 · 48 (5) · 489

DOI: 10.3390/cimb48050489 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 08.05.2026. Verfasst von Wei Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jilin Province Science and Technology Department, Science and Technology Development Plan Project of Jilin Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bladder cancer remains a major clinical challenge because of its high recurrence rate, marked molecular heterogeneity, frequent progression, and limited durability of current therapeutic strategies. Increasing evidence indicates that acetylation, as a reversible and druggable epigenetic modification, plays a central role in bladder cancer biology by linking chromatin remodeling to transcriptional regulation, DNA damage repair, metabolic adaptation, and immune modulation. Both histone and non-histone acetylation are frequently dysregulated in bladder cancer, and these alterations contribute to multiple malignant phenotypes, including sustained proliferation, defective cell-cycle control, apoptosis evasion, epithelial–mesenchymal transition, metastatic progression, and therapeutic resistance. In this review, we summarize the mechanistic basis of acetylation imbalance in bladder cancer, with particular emphasis on the roles of histone acetyltransferases, histone deacetylases, sirtuins, and acetylation-associated metabolic regulators. We further discuss the emerging evidence that natural products can modulate acetylation-related pathways in bladder cancer, mainly through targeting HDAC-dependent histone deacetylation and SIRT1-associated non-histone deacetylation. Representative compounds, including sulforaphane, erucin, puerarin, capsaicin, curcumin, trichostatin A, trichostatin C, and pinocembrin, highlight the potential of natural products to suppress tumor growth, promote apoptosis, impair migration, and enhance antitumor immunity through acetylation-related mechanisms. Beyond summarizing individual agents, the evidence was evaluated based on the integration of acetylation-related target engagement, acetylation remodeling, and bladder cancer-relevant phenotypic outcomes. The current evidence is heterogeneous. SFN/ECN, capsaicin, and pinocembrin offer the most convincing bladder cancer-specific support, whereas several other compounds remain limited by context-dependent effects, indirect pathway inference, or incomplete validation of the proposed acetylation mechanisms. These findings support an evidence-oriented translational framework that prioritizes natural products according to mechanistic robustness, bladder cancer specificity, and combination potential. Overall, acetylation-targeting natural products represent a promising but still evolving therapeutic strategy for bladder cancer, warranting further subtype-specific, mechanistically rigorous, and translationally oriented investigation.

Schlagwörter

Stichwörter der Autor:innen

acetylationbladder cancerepigenetic modificationnatural product

Autor:innen und Institutionen

  • College of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China.
  • Public Experimental Center, Changchun University of Chinese Medicine, Changchun 130117, China.
  • School of Clinical Medicine, Changchun University of Chinese Medicine, Changchun 130117, China.
  • College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun 130117, China.

ORCID-Profile: Yang Liu

Förderung

  • Jilin Province Science and Technology Department
  • Science and Technology Development Plan Project of Jilin Province

Zitieren

APA

Li, W., Liu, D., Yin, Q., Geng, Y., Liu, Y., & Wang, Y. (2026). Natural Products Targeting Acetylation in Bladder Cancer: Mechanistic Basis, Therapeutic Potential, and Future Perspectives. Current Issues in Molecular Biology, 48(5), 489. https://doi.org/10.3390/cimb48050489

Vancouver

Li W, Liu D, Yin Q, Geng Y, Liu Y, Wang Y. Natural Products Targeting Acetylation in Bladder Cancer: Mechanistic Basis, Therapeutic Potential, and Future Perspectives. Current Issues in Molecular Biology. 2026;48(5):489. doi:10.3390/cimb48050489

BibTeX
@article{Li2026,
  author = {Li, Wei and Liu, Da and Yin, Qinzhamusu and Geng, Yiwen and Liu, Yang and Wang, Yong},
  title = {Natural Products Targeting Acetylation in Bladder Cancer: Mechanistic Basis, Therapeutic Potential, and Future Perspectives},
  journal = {Current Issues in Molecular Biology},
  year = {2026},
  volume = {48},
  number = {5},
  pages = {489},
  doi = {10.3390/cimb48050489}
}
Kostenlos starten →